Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

For cell and gene therapy, a consistent supply of quality starting material is vital that is maintained throughout the ...

Orsini, a leader in rare disease pharmacy solutions, has been selected by Neurotech Pharmaceuticals, Inc., as the exclusive ...

Health plans often limit physical therapy to 20 or 30 sessions, even for people who may need months of treatment, multiple ...

Q4 2024 Earnings Call Transcript March 31, 2025 Celcuity Inc. misses on earnings expectations. Reported EPS is $-0.85 EPS, ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

Q4 2024 Earnings Call Transcript March 31, 2025 Brainstorm Cell Therapeutics Inc. reports earnings inline with expectations.

For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...

Michigan legislators are moving to regulate hyperbaric oxygen chambers following the January death of a 5-year-old patient ...

Discover what every stage of breast cancer means for treatment options and recovery, with expert insights to help navigate a ...

This investigational treatment was generally well tolerated with no serious adverse events; fewer adverse events related to non-motor symptoms were reported in the solengepras arm Pivotal Phase 3 ...

New REVEAL-1 study results show early signs of weight maintenance after GLP-1 discontinuationREMAIN-1 pivotal study now more than 50% enrolled; ...